Showing 1,657 news articles about Hepatitis & HIV

Filters Content type: Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Hepatitis & HIV

Hep C deaths outpace HIV; new drugs, services for coinfected

Editor's pick
Bay Area Reporter
23 November 2011
New & experimental hepatitis C treatment

University launches iphone app for hepatitis treatment

Editor's pick
Eurekalert Medicine & Health
22 November 2011
Pharmaceutical industry

HIV Drug Giant Gilead Acquires Pharmasset, a Hep C Drug Development Leader

Editor's pick
AIDSMeds.com
21 November 2011
Hepatitis C transmission & prevention

AASLD: Epidemic of Sexually Transmitted HCV among HIV+ Gay Men in Amsterdam Levels Off

Editor's pick
HIVandHepatitis.com
21 November 2011
Hepatitis C treatment

Adverse CNS Effects of HCV Treatment Discourage Adherence

Editor's pick
Medscape (requires free registration)
21 November 2011
Hepatitis & HIV

No HIV Disease Progression in Transplant Recipients

Editor's pick
Medscape (requires free registration)
19 November 2011
Hepatitis C symptoms & diagnosis

Can simple blood tests predict liver cancer?

Editor's pick
CATIE
18 November 2011
Ageing & HIV

Tailored Risk Profiles Guide Care of HIV Patients

Editor's pick
Medscape (requires free registration)
17 November 2011
Liver disease

Blood Thinner Reduces Liver Vein Blood Clots, Protects Liver Functioning in People With Cirrhosis

Editor's pick
Kaiser Daily Global Health Policy Report
17 November 2011
Hepatitis C treatment

Blood Thinner Reduces Liver Vein Blood Clots, Protects Liver Functioning in People With Cirrhosis

Editor's pick
AIDSMeds
17 November 2011
Health problems & ageing

AMA Supports Allowing Research on Organ Transplantation Between HIV-Infected Individuals

Editor's pick
American Medical Association
15 November 2011
Hepatitis & HIV

Hepatitis C Surpasses HIV as Cause of Death in U.S.

Editor's pick
AIDSMeds
10 November 2011
New & experimental hepatitis C treatment

Transgene’s Therapeutic HCV Vaccine TG4040 Combined with Commonly Used Treatment Achieves Substantial Viral Suppression in Randomized Phase II trial

Editor's pick
Transgene press release
8 November 2011
New & experimental hepatitis C treatment

All-Oral Treatment Regimen of Bristol-Myers Squibb’s Investigational NS5A and NS3 Inhibitors Achieved 90% Sustained Virologic Response (SVR12) in Phase II Study Sentinel Cohort of Genotype 1b Null Responders

Editor's pick
Bristol-Myers Squibb press release
8 November 2011
New & experimental hepatitis C treatment

Interferon-free combination of BI 201335 plus BI 207127 and ribavirin shows up to 76% of patients achieve a virological response at week 12, and 59% achieve SVR12 with 16 weeks treatment

Editor's pick
Boehringer Ingelheim press release
8 November 2011
New & experimental hepatitis C treatment

Novartis DEB025 data showed viral clearance as early as six weeks and potential for interferon-free therapy in hepatitis C patients

Editor's pick
Novartis (press release)
7 November 2011
New & experimental hepatitis C treatment

Positive Interim Data From a Phase 2 Study of INCIVEK(TM) (telaprevir) Combination Therapy in People Co-Infected with Hepatitis C and HIV Presented at The Liver Meeting(R)

Editor's pick
Vertex (press release)
7 November 2011
New & experimental hepatitis C treatment

Twelve Weeks Interferon-Free PSI-7977 Regimen Cures 100 Percent Hep C Genotype 2/3

Editor's pick
AIDSMeds
6 November 2011
New & experimental hepatitis C treatment

Copy of Twelve Weeks Interferon-Free PSI-7977 Regimen Cures 100 Percent Hep C Genotype 2/3

Editor's pick
Kaiser Daily Global Health Policy Report
6 November 2011
New & experimental hepatitis C treatment

AASLD-Santaris Phase 2a Data of Miravirsen Shows Dose-Dependent, Prolonged Viral Reduction of 2-3 Logs HCV RNA After Four-Week

Editor's pick
Santaris press release
5 November 2011
New & experimental hepatitis C treatment

Pharmasset rises on new hepatitis C drug studies

Editor's pick
Bloomberg BusinessWeek
2 November 2011
New & experimental hepatitis C treatment

TMC435-Based Therapy Significantly Improved Viral Cure Rates in Patients Who Failed Prior Treatment for Hepatitis C

Editor's pick
Business Wire
2 November 2011
New & experimental hepatitis C treatment

Pharmasset Takes Lead in Race to Develop Hep C Therapy By Pill

Editor's pick
The Street
1 November 2011
Hepatitis C transmission & prevention

Hepatitis transmission risk needs to be studied in nail salons, barbershops

Editor's pick
Eurekalert Medicine & Health
31 October 2011